remission medical logo
a woman sits in a chair and types on her laptop while holding her cellphone

Power of Telemedicine in Rheum

In this RheumatologyAdvisor article from March of 2022, the finding revealed is that “as the pandemic advanced, through the spring and summer of 2020, we found that participants in urban vs rural zip codes more frequently avoided office visits and testing for their autoimmune condition and also had the most use of telemedicine services.”

The major theme of the piece is that Social Determinants of Health (SDOH) issues go hand in hand with virtual visits; there needs to be some assurance that it provides quality care to all patients.

Our view at Remission Medical is that telemedicine in Rheumatology can drive a far faster mean Time To Diagnosis (TTD), significantly increase Appointments Adherence, and improve access for the full range of patients across Commercial, Medicare and Medicaid.

The article says—

Telemedicine is particularly valuable for people living with rheumatic conditions because these patients are at potentially elevated risk for worse COVID-19 outcomes due to comorbidities and the use of immunosuppressive drugs such as glucocorticoids and biologics that heighten risk for infections and require close monitoring for side effects.

Telemedicine in 2022 America is about more than just convenience; it’s creating new versions of tried-and-true clinical pathways that are more efficacious and represent lower costs for Payers and Patients alike.